An observational study in Cardiac Arrest, sponsored by Versailles Hospital. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-07-20.
Sponsored by Versailles Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 106 studies in Heart Arrest with a site in France — 32 open to participants now, 33 under way, 3 of them phase 3. Heart Arrest · France.
Among the 106 studies in Heart Arrest with a site in France, this one is the 5th largest by planned enrollment of the 47 observational ones that give a count, is one of 3 that started in 2006, is one of 47 observational ones, reaches primary completion later than 11 of the 32 other live ones, and was the 51st registered.
927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
Browse Heart Arrest studies →32 of the 106 studies in Heart Arrest with a site in France are open now. Recruiting first, the newest first:
Nantes University Hospital · Sites in France, Belgium, Guadeloupe
Ages 18+
University Hospital, Toulouse · Sites in France
Ages 18+
Nantes University Hospital · Sites in France
Ages 18+
University Hospital, Toulouse · Sites in France
Ages 18+ · Healthy volunteers
Versailles Hospital · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
106 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2006.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,000 is above the median of 200 across 376 observational studies indexed under Heart Arrest.
Median enrollment 106 across the 59 interventional studies, 150 across the 47 observational. Of the 62 that completed or were terminated, 3 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 106 have an industry lead sponsor. The 10 most frequent:
Versailles Hospital is the lead sponsor of 74 studies on the registry; 16 are open to participants now.
Versailles Hospital has 2 studies filed under Heart Arrest — fewer than ten, so there is no comparison to draw.
8 of the studies in Heart Arrest with a site in France that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06835491Phase 3Versailles HospitalProphylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm | 2027-01-15 |
| NCT03594318Versailles HospitalVersailles Hospital Cardiac Arrest Registry | 2026-12 |
| NCT06387225Nantes University HospitalEarly and Objective Assessment of Neurological Prognosis in Cardiac Arrest Patients | 2027-05-31 |
| NCT05961488CHU de ReimsPerformance of Coronary CT Angiography to Rule Out Coronary Artery Disease After Out-of-hospital Cardiac Arrest | 2027-06 |
| NCT06780722Nantes University HospitalStudy of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Procedure | 2027-06-06 |
Add all 8 to your calendar (.ics) → With an account.
Among the 106 studies in Heart Arrest with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Out-of-hospital and in-hospital cardiac arrest (CA) requiring intensive care unit management.
Data collection using a standardized form : demographic data and data related to the CA according to the Utstein guidelines.. Circumstances of onset, dates and times of onset and control of abnormal movements (myoclonus and.or seizures).
On-scene clinical findings, pre-hospital and hospital care providers, timing of various treatments and supportive care, results of etiological investigations, cause of CA. Dates and times of EEG monitoring, EEG results. Outcomes including vital status and Cerebral Performance Category scale score at ICU and hospital discharge, day-90 and 1-year after CA and determined based on data in the ICU and/or hospital/neurologist charts and/or general practitionner phone interview.
Cardiac arrest requiring Intensive Care Unit Management
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Long term favorable outcome
A favorable outcome is defined by a Cerebral Performance Category scale score (CPC) of 1 or 2. The Cerebral Performance Category scale score will be determined according to hospital charts and/or general practitioner phone interview. The CPC score : \[5: Death, 4: Persistent vegetative state, 3: Severe disability, 2: Moderate disability, 1 : Low disability\]
Time frame: 1 year
Short term favorable outcome
A favorable outcome is defined by a Cerebral Performance Category scale score (CPC) of 1 or 2. The Cerebral Performance Category scale score will be determined according to hospital charts and/or general practitioner phone interview. The CPC score : \[5: Death, 4: Persistent vegetative state, 3: Severe disability, 2: Moderate disability, 1 : Low disability\]
Time frame: 3 months
Postanoxic Status Epilepticus
Postanoxic Status Epilepticus occurence as defined by EEG abnormalities based on the Salzburg Criteria
Time frame: 28 days
Complications of anticoagulant/ antiplatelet therapies
Any bleeding requiring \>2 Units Red Blood Cell transfusion
Time frame: 28 days
Short term quality of life as assessed by the Short Form (36) Health Survey (SF36)
Description of global SF36 score and each of its eight sections (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental health).
Time frame: 3 months
Long term quality of life as assessed by the Short Form (36) Health Survey (SF36)
Description of global SF36 score and each of its eight sections (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental health).
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2006 (actual). Primary completion is estimated for Dec 2026, 251 months after the start.
Of 169 non-industry observational studies under Heart Arrest, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 96. This study's planned 251 months is above that.
Counting every sponsor, half of 176 studies reached it within 41 months; a quarter within 18 and three quarters within 90.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Versailles Hospital